Concepedia

Marja-Liisa Dahl

MD

13

Publications

1.2K

Citations

13

H-Index

1992

Active since

Affiliations

Karolinska Institutet(Current)

Universidad de Extremadura

Uppsala University Hospital

Integrated Cardio Metabolic Centre

University of Beira Interior

Marja-Liisa Dahl is an author at Karolinska Institutet specializing in medicine, pharmacology, and pharmacogenomics.

Top concepts

Publications per year

1992–2003

13

Publications

13

Validation of Methods for CYP2C9 Genotyping: Frequencies of Mutant Alleles in a Swedish Population

Ümit Yaşar, Erik Eliasson, Marja-Liisa Dahl et al. · Biochemical and Biophysical Research Communications · 1999 · 252 citations

, , +13

Use of omeprazole as a probe drug for CYP2C19 phenotype in Swedish Caucasians: comparison with S-mephenytoin hydroxylation phenotype and CYP2C19 genotype

Ming Chang, Marja-Liisa Dahl, Gunnel Tybring et al. · Pharmacogenetics · 1995 · 203 citations

CYP2C19 genotype and phenotype determined by omeprazole in a Korean population

Hyung‐Keun Roh, Marja-Liisa Dahl, Gunnel Tybring et al. · Pharmacogenetics · 1996 · 119 citations

, , +18

The CYP2D6 genotype predicts the oral clearance of the neuroleptic agents perphenazine and zuclopenthixol*

Markus Jerling, Marja-Liisa Dahl, Anna Åberg-Wistedt et al. · Clinical Pharmacology & Therapeutics · 1996 · 100 citations

CYP2C9 genotypes and diclofenac metabolism in Spanish healthy volunteers

Pedro Dorado, Roland Berecz, Maria-Jes�s Norberto et al. · European Journal of Clinical Pharmacology · 2003 · 100 citations

, , +3

Rows per page

1–5 of 13